HOLX Hologic, Inc.
Healthcare$76.01+0.00%ClosedMarket Cap: $16.97B
As of 2026-05-26
Valuation
P/E (TTM)
31.20
PEG
—
P/B
3.25
P/S
4.11
EV/EBITDA
17.08
DCF Value
$108.60
FCF Yield
5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.8%
Operating Margin
17.5%
Net Margin
13.2%
ROE
11.0%
ROA
5.9%
ROIC
7.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.05B | 56.0% | $237.0M | $179.1M | $— | — |
| Q4 null | $1.05B | 60.9% | $237.0M | $187.3M | $— | — |
| FY null | $4.10B | 61.0% | $714.3M | $565.7M | $— | — |
| Q3 null | $1.02B | 56.3% | $254.6M | $194.9M | $— | — |
| Q2 null | $1.01B | 37.5% | $-7.0M | $-17.4M | $— | — |
| Q1 null | $1.02B | 56.8% | $229.8M | $201.0M | $— | — |
| Q4 null | $988.0M | 56.4% | $230.0M | $178.6M | $— | — |
| FY null | $4.03B | 55.3% | $882.6M | $789.5M | $— | — |
| Q3 null | $1.01B | 55.4% | $244.0M | $194.5M | $— | — |
| Q2 null | $1.02B | 55.3% | $243.3M | $169.9M | $— | — |
| Q1 2024 | $1.01B | 56.0% | $198.2M | $246.5M | $1.03 | — |
| Q4 2023 | $945.3M | 52.9% | $132.5M | $90.6M | $0.37 | — |